HIMS

$25.701.82%0.46

Nachbörslich: 25.82+0.12 +0.47%

Hims Hers Health Inc (HIMS)

Date: O: H: L: C: Vol:

Schlusskurs vom Vortag:

$25.24

Offen:

$25.48

24-Stunden-Volumen:

7,339,060

Relatives Volumen:

0.85

Marktkapitalisierung:

$6.00B

Einnahmen:

$2.35B

Nettoeinkommen (Verlust:

$128.37M

KGV:

49.22

EPS:

$0.5221

Netto-Cashflow:

$57.42M

1W Leistung:

-7.95%

1M Leistung:

-11.38%

6M Leistung:

-6.24%

1Y Leistung:

-42.10%

1-Tages-Spanne:

$25.40$26.37

1-Wochen-Bereich:

$25.15$30.13

52-Wochen-Spanne:

$13.74$48.34

Hims Hers Health Inc Aktie (HIMS) Unternehmensprofil

Firmenname

Hims Hers Health Inc

Sektor

Healthcare

Branche

Drug Manufacturers - Specialty & Generic

Telefon

415-851-0195

Adresse

2269 CHESTNUT ST, SAN FRANCISCO, USA

Mitarbeiter

2,442

Nächster Verdiensttermin

2026-11-09

Neueste SEC-Einreichungen

SEC

HIMS-Diskussionen auf X

Marktkapitalisierung

Umsatz

Nettogewinn

Free Cashflow

ENV

Hims Hers Health Inc Aktie (HIMS) Hochstufungen & Herabstufungen

Datum	Aktion	Analytiker	Ratingänderung
2026-09-11	Resumed	JP Morgan	Neutral
2026-05-12	Bestätigt	Needham	Buy
2026-04-24	Eingeleitet	JP Morgan	Overweight
2026-03-10	Hochstufung	BofA Securities	Underperform → Neutral
2026-03-10	Hochstufung	Citigroup	Sell → Neutral
2026-03-09	Hochstufung	Needham	Hold → Buy
2026-02-24	Herabstufung	BTIG Research	Buy → Neutral
2026-01-12	Eingeleitet	Evercore ISI	In-line
2025-12-09	Eingeleitet	Barclays	Overweight
2025-10-21	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2025-06-23	Herabstufung	Needham	Buy → Hold
2025-06-04	Bestätigt	Needham	Buy
2025-04-29	Herabstufung	TD Cowen	Buy → Hold
2025-02-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-01-10	Herabstufung	Citigroup	Neutral → Sell
2025-01-07	Eingeleitet	BTIG Research	Buy
2024-12-17	Eingeleitet	Morgan Stanley	Overweight
2024-11-14	Herabstufung	BofA Securities	Buy → Underperform
2024-08-22	Eingeleitet	Needham	Buy
2024-08-09	Herabstufung	Imperial Capital	Outperform → In-line
2024-05-22	Herabstufung	Citigroup	Buy → Neutral
2024-04-16	Herabstufung	Jefferies	Buy → Hold
2024-04-10	Eingeleitet	Canaccord Genuity	Buy
2024-02-28	Hochstufung	Imperial Capital	In-line → Outperform
2024-02-26	Eingeleitet	Leerink Partners	Market Perform
2023-12-07	Eingeleitet	Imperial Capital	In-line
2023-07-28	Eingeleitet	TD Cowen	Outperform
2023-04-11	Eingeleitet	Robert W. Baird	Neutral
2023-02-09	Hochstufung	Jefferies	Hold → Buy
2022-11-08	Hochstufung	BofA Securities	Neutral → Buy
2022-11-08	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2022-10-17	Herabstufung	Piper Sandler	Overweight → Neutral
2022-09-07	Eingeleitet	Truist	Hold
2022-07-15	Eingeleitet	SVB Leerink	Underperform
2022-04-14	Eingeleitet	Guggenheim	Buy
2022-04-01	Resumed	Credit Suisse	Outperform
2022-03-10	Eingeleitet	Deutsche Bank	Hold
2021-12-02	Eingeleitet	Jefferies	Hold
2021-11-11	Hochstufung	Piper Sandler	Neutral → Overweight
2021-07-06	Eingeleitet	BofA Securities	Neutral
2021-05-20	Hochstufung	Credit Suisse	Neutral → Outperform
2021-04-21	Eingeleitet	Truist	Hold
2021-03-09	Eingeleitet	Credit Suisse	Neutral
2021-03-02	Hochstufung	Citigroup	Neutral → Buy
2021-02-17	Eingeleitet	Citigroup	Neutral
2021-02-12	Eingeleitet	Piper Sandler	Neutral
2021-02-08	Eingeleitet	Tigress Financial	Buy

Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)

Zeitraum	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Enddatum des Zeitraums	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	2,347.64	1,476.51	872.00	526.92	271.88
Cost of revenue USD (M)	614.26	303.38	157.05	118.19	67.38
Gross profit USD (M)	1,733.38	1,173.14	714.95	408.72	204.49
Operating expenses USD (M)	1,627.77	1,111.23	744.40	477.42	319.54
Operating income USD (M)	105.61	61.90	-29.45	-68.70	-115.04
Income before tax USD (M)	123.92	71.71	-21.57	-65.71	-110.80
Income tax expense USD (M)	-4.44	-54.33	1.98	-0.03	-3.14
Net income USD (M)	128.37	126.04	-23.55	-65.68	-107.66
Basic EPS USD/shares	0.57	0.58	-0.11	-0.32	-0.58
Diluted EPS USD/shares	0.51	0.53	-0.11	-0.32	-0.58
Basic weighted shares shares (M)	224.96	215.94	209.34	204.52	186.78
Diluted weighted shares shares (M)	258.23	236.81	209.34	204.52	186.78
Selling, general and administrative USD (M)	-	-	-	-	183.63

Hims Hers Health Inc-Aktie (HIMS) Insiderhandel

Boughton SoleilOct 28 '26
Officer
Transaktion
Proposed Sale
Kosten
$27.60
#Aktien
3,462
Wert ($)
95,551
#Aktien Gesamt
0
Boughton SoleilOct 28 '26
Chief Legal Officer
Transaktion
Sale
Kosten
$27.60
#Aktien
3,462
Wert ($)
95,551
#Aktien Gesamt
293,886
Boughton SoleilOct 14 '26
Officer
Transaktion
Proposed Sale
Kosten
$29.06
#Aktien
3,461
Wert ($)
100,577
#Aktien Gesamt
0
Boughton SoleilOct 14 '26
Chief Legal Officer
Transaktion
Sale
Kosten
$29.06
#Aktien
3,461
Wert ($)
100,577
#Aktien Gesamt
297,348
Okupe OluyemiOct 01 '26
Officer
Transaktion
Proposed Sale
Kosten
$29.70
#Aktien
2,000
Wert ($)
59,400
#Aktien Gesamt
0
Okupe OluyemiOct 01 '26
Chief Financial Officer
Transaktion
Sale
Kosten
$29.70
#Aktien
2,000
Wert ($)
59,400
#Aktien Gesamt
234,527
Boughton SoleilSep 30 '26
Officer
Transaktion
Proposed Sale
Kosten
$29.17
#Aktien
3,461
Wert ($)
100,957
#Aktien Gesamt
0
Boughton SoleilSep 30 '26
Chief Legal Officer
Transaktion
Sale
Kosten
$29.17
#Aktien
3,461
Wert ($)
100,957
#Aktien Gesamt
300,809
Okupe OluyemiSep 22 '26
Chief Financial Officer
Transaktion
Sale
Kosten
$29.95
#Aktien
29,277
Wert ($)
876,846
#Aktien Gesamt
236,527
Okupe OluyemiSep 22 '26
Officer
Transaktion
Proposed Sale
Kosten
$29.95
#Aktien
29,277
Wert ($)
876,846
#Aktien Gesamt
0

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
Boughton Soleil	Officer	Oct 28 '26	Proposed Sale	$27.60	3,462	95,551	0
Boughton Soleil	Chief Legal Officer	Oct 28 '26	Sale	$27.60	3,462	95,551	293,886
Boughton Soleil	Officer	Oct 14 '26	Proposed Sale	$29.06	3,461	100,577	0
Boughton Soleil	Chief Legal Officer	Oct 14 '26	Sale	$29.06	3,461	100,577	297,348
Okupe Oluyemi	Officer	Oct 01 '26	Proposed Sale	$29.70	2,000	59,400	0
Okupe Oluyemi	Chief Financial Officer	Oct 01 '26	Sale	$29.70	2,000	59,400	234,527
Boughton Soleil	Officer	Sep 30 '26	Proposed Sale	$29.17	3,461	100,957	0
Boughton Soleil	Chief Legal Officer	Sep 30 '26	Sale	$29.17	3,461	100,957	300,809
Okupe Oluyemi	Chief Financial Officer	Sep 22 '26	Sale	$29.95	29,277	876,846	236,527
Okupe Oluyemi	Officer	Sep 22 '26	Proposed Sale	$29.95	29,277	876,846	0

Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten

Nov 01, 2026

HIMS Deadline in 1 Day: Hims & Hers Health, Inc. (NYSE: HIMS) Class Action Lawsuit Seeks Recovery for Investors; November 2, 2026 Deadline- Contact Kessler Topaz Meltzer & Check, LLP - GlobeNewswire Inc.

Nov 01, 2026

מחר המועד האחרון בעניין HIMS: רוזן, עורך דין מומחה למשקיעים, קורא למשקיעי Hims & Hers Health, Inc שספגו הפסדים העולים על 100,000 דולר, לשכור ייצוג משפטי לקראת המועד החשוב ב-2 בנובמבר במסגרת תביעה ייצוגית בענייני ניירות ערך – HIMS - GlobeNewswire Inc.

Nov 01, 2026

Oct 31, 2026

DOCS DEADLINE: ROSEN, A LONGSTANDING FIRM, Encourages Doximity, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – DOCS - GlobeNewswire Inc.

Oct 31, 2026

HIMS FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 2 Deadline in Securities Class Action - HIMS - GlobeNewswire Inc.

Oct 31, 2026

Oct 29, 2026

Bronstein, Gewirtz & Grossman LLC Urges Hims & Hers Health, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.

Oct 29, 2026